Cliantha Research Limited

Cliantha Research, full-service clinical research organization (CRO), provides comprehensive and integrated offerings in Early Phase (BA/BE and Phase I) trials, Late Phase (Phase II-IV) patient-based trials, Consumer Clinical Research, Bioanalytical, IVRT/IVPT, Biometrics, Medical Services, Allergy Testing - Environmental Exposure Chambers (EECs) and Veterinary Therapeutics (Preclinical-Bioanalytical). Cliantha, by leveraging on the depth of experience provides ethical, value-added customer centric services rooted in excellence, thereby enabling clinical development of pharmaceutical, biotech & healthcare companies. With strategic acquisitions globally, Cliantha has widened the horizon of clinical research & support services for end-to-end developmental needs across. With over 21 years of excellence in clinical research, we continue to advance studies across diverse therapeutic areas—leveraging innovation to drive efficiency throughout every phase of the clinical development process. With state-of-the-art clinical sites and bioanalytical laboratories across India and North America, Cliantha has expanded its footprint to three countries, and is supported by a strong team of over 1,500 professionals. Cliantha has successfully undergone inspections by major global regulatory authorities, including the US FDA, EU (AGES, ANSM, AEMPS), UK MHRA, ANVISA (Brazil), NPRA (Malaysia), GCC-DR, TITCK (Turkey), WHO, MCC (South Africa),CAP, NABL, and others—underscoring its commitment to global quality and regulatory excellence.